🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we're supporting the launch of #CARTVision, because every eligible patient should get the opportunity for cure with CAR T-cell therapy. It’s going to take a broad coalition working together to make the CAR T Vision a reality. Join us: bit.ly/3GXqHDE

Today, on National Cancer Survivors Day, we honour every lymphoma survivor - those who have been diagnosed, undergone treatment, and are now living in remission. At Lymphoma Canada, we recognize and celebrate your strength, courage, and resilience. lymphoma.ca

Lorna Warwick, CEO of Lymphoma Coalition, contributed to a publication in HemaSphere titled "European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological Malignancies." The article outlines standards aimed at improving care for people with blood

Excellent report outlining vital aspects of quality care for haematological cancers throughout Europe. Well worth a read!

📣 The updated Lymphoma Patient Charter is now LIVE! The Lymphoma Patient Charter offers a structured summary of the key priorities expressed by people with lived experience with lymphoma, outlining patient-centred principles in lymphoma care. Developed with input from people

🌍 Lymphoma Coalition at EHA 2025 📸 Pictured: Lymphoma Coalition representatives attending the Congress – Natacha Bolaños (Head, Membership & Alliances), Kathryn Perry (Head of Information and Communications), and Lorna Warwick (Chief Executive Officer). The EHA 2025 Congress

Even in care planning, women are less likely to feel heard. 💬 Quality of life must be prioritized. Let’s ensure every patient voice counts ! #EHA2025 Lymphoma Coalition

📢 Presentation Highlight – EHA 2025 During EHA 2025, Natacha Bolaños, Head, Membership & Alliances at Lymphoma Coalition, presented during the EHA Lymphoma Group session on “Lymphoma treatment – When to start, when to stop and how to judge outcomes: What is really important for

Lymphoma Coalition is pleased to see this important research on chronic lymphocytic leukemia (#CLL) care featured at #EHA2025. The poster and abstract focus on advancing shared decision-making in CLL, ensuring that care reflects the individual goals, preferences, and values of

Lorna Warwick from Lymphoma Coalition at #EHA2025 on how unaddressed side effects undermine patient confidence in lymphoma and CLL. ajmc.com/view/unaddress…

Save the date! Our next webinar series will run throughout July - stay tuned for updates

📣 During #EHA25, Lorna Warwick, CEO of Lymphoma Coalition, spoke with The American Journal of Managed Care (AJMC) about the often-overlooked impact of side effects for people living with lymphoma and chronic lymphocytic leukemia (CLL). In the first part of this interview, Lorna

In this interview, @LornaWarick, CEO of the Lymphoma Coalition / Lymphoma Coalition, discusses the adverse effects experienced by patients with #lymphoma and #chroniclymphocyticleukemia, and how it impacts their well-being if left unaddressed. Watch now! hubs.li/Q03sbGVQ0

25 Posts Not to Miss from EHA 2025 (European Hematology Association) ASH | Nico Gagelmann | Lymphoma Coalition | Daniel Auclair | Talha Badar | Ajay Major, MD, MBA | C. Ola Landgren, M.D. | Vincent Rajkumar | Vivek Subbiah, MD | Anna Sureda | Amer Zeidan MBBS,MHS ‏عامر زيدان | Sanam Loghavi, MD صنم لغوی 🔬🧬 | Sabrina Ranero Ferrari

“We’re not just focused on medical outcomes—we have to listen more and more to the patient voice.” Filmed at #18ICML, Professor Marek Trněný, Chair of the Czech Lymphoma Study Group and Fellow of the Learned Society of the Czech Republic, speaks to the growing importance of

In the second and final part of her interview with The American Journal of Managed Care at #EHA2025, Lorna Warwick, CEO of Lymphoma Coalition, expands on the findings of the abstract: The Effect of Unaddressed Side Effects on Patient-Reported Confidence in Care Plans Among

During ICML 2025, Lorna Warwick, CEO of Lymphoma Coalition and member of the CAR T Vision Coalition Steering Committee, was invited to speak with VJHemOnc about the newly launched initiative, highlighting the importance of incorporating the patient perspective to improve access

At #EHA2025, Lorna Warwick, CEO of the Lymphoma Coalition (Lymphoma Coalition), highlights findings underscoring the vital role of clinician communication in managing adverse effects and supporting patient confidence in #lymphoma and #CLL care. Watch here: bit.ly/4lgL4Lz

Pathogens and Lymphoma webinar series starts tomorrow - EBV and lymphomagenesis with Marie Donzel, Jennifer Amengual, Amira Marouf, Florence Broussais-Guillaumot & Soni Smith MD Register to join live ➡️ us06web.zoom.us/webinar/regist…